- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Werewolf Therapeutics Inc (HOWL)
Werewolf Therapeutics Inc stock price live, this page displays NASDAQ HOWL stock exchange data. View the HOWL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Werewolf Therapeutics Inc real time stock price chart below.
What Is the Werewolf Therapeutics Inc Stock Price Today?
The Werewolf Therapeutics Inc stock price today is 1.35.
What Is the Stock Symbol for Werewolf Therapeutics Inc?
The stock symbol for Werewolf Therapeutics Inc is ""HOWL.""
What Stock Exchange Does Werewolf Therapeutics Inc Trade On?
Werewolf Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Werewolf Therapeutics Inc a Good Stock to Buy?
Determining whether Werewolf Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HOWL quote. (ISIN: US95075A1079)
What Is the Werewolf Therapeutics Inc Stock Price Today?
The Werewolf Therapeutics Inc stock price today is 1.35.
What Is the Stock Symbol for Werewolf Therapeutics Inc?
The stock symbol for Werewolf Therapeutics Inc is ""HOWL.""
What Stock Exchange Does Werewolf Therapeutics Inc Trade On?
Werewolf Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Werewolf Therapeutics Inc a Good Stock to Buy?
Determining whether Werewolf Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HOWL quote. (ISIN: US95075A1079)
NASDAQ
Currency in USD
1.35
-0.01(-0.74%)
Real-time Data·
Fair Value
An estimate of a Werewolf Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.35
1.41
52 wk Range
0.60
4.18
HOWL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
HOWL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Werewolf Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.351.41
52 wk Range
0.604.18
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HOWL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Werewolf Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
7.17
Upside
+430.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Werewolf Therapeutics Inc Company Profile
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Werewolf Therapeutics Inc SWOT Analysis
Pipeline Progress | Explore Werewolf's advancing clinical trials, with WTX-124 nearing crucial milestones and WTX-330 entering Phase 1/2 studies in Q1 2025 |
Platform Potential | Discover how Werewolf's PREDATOR platform is expanding beyond oncology into inflammatory diseases, opening new market opportunities |
Financial Strength | Learn about Werewolf's robust $122.8M cash position, funding operations until Q2 2026, and its strategic partnership with Jazz Pharmaceuticals |
Market Outlook | Delve into Werewolf's pivotal year ahead, with multiple data updates expected and a reduced analyst price target of $4, down from $12 |
Compare HOWL to Peers and Sector
Metrics to compare | HOWL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHOWLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −1.2x | −0.5x | |
PEG Ratio | 0.05 | −0.05 | 0.00 | |
Price/Book | 1.5x | 1.7x | 2.6x | |
Price / LTM Sales | - | 8.2x | 3.3x | |
Upside (Analyst Target) | - | 280.7% | 38.7% | |
Fair Value Upside | Unlock | 28.0% | 5.0% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.17
(+430.86% Upside)
Earnings
Latest Release
Aug 14, 2025
EPS / Forecast
-0.40 / -0.47
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Werewolf Therapeutics Trade On?
Werewolf Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Werewolf Therapeutics?
The stock symbol for Werewolf Therapeutics is "HOWL."
What Is the Werewolf Therapeutics Market Cap?
As of today, Werewolf Therapeutics market cap is 61.73M.
What Is Werewolf Therapeutics's Earnings Per Share (TTM)?
The Werewolf Therapeutics EPS (TTM) is -1.64.
When Is the Next Werewolf Therapeutics Earnings Date?
Werewolf Therapeutics will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is HOWL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Werewolf Therapeutics Stock Split?
Werewolf Therapeutics has split 0 times.
How Many Employees Does Werewolf Therapeutics Have?
Werewolf Therapeutics has 46 employees.
What is the current trading status of Werewolf Therapeutics (HOWL)?
As of 27 Aug 2025, Werewolf Therapeutics (HOWL) is trading at a price of 1.35, with a previous close of 1.36. The stock has fluctuated within a day range of 1.35 to 1.41, while its 52-week range spans from 0.60 to 4.18.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.